Levetiracetam Brill Pharma (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which regulates neurotransmitter release. This binding reduces excessive synaptic firing and neuronal excitability, thereby limiting the spread of epileptic discharges across the brain.

The specific dose of levetiracetam is individualized by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Dosage adjustments are made to achieve optimal seizure control while minimizing side effects.

Levetiracetam’s pregnancy category is listed as unknown, meaning safety data are limited. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the medication.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with older antiepileptics such as carbamazepine or phenytoin, levetiracetam has a simpler pharmacokinetic profile, fewer drug‑enzyme interactions, and is generally well tolerated. However, individual response varies, and clinicians choose therapy based on seizure type, comorbidities and patient tolerance.

Levetiracetam Brill Pharma should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight to maintain product stability.

Levetiracetam is taken orally, usually as a tablet or oral solution, with or without food. The exact administration schedule—once daily, twice daily, or more—depends on the prescriber’s instructions and the patient’s therapeutic needs.

Serious risks include severe allergic reactions such as anaphylaxis, life‑threatening skin conditions like Stevens‑Johnson syndrome, and psychiatric effects including suicidal thoughts or severe mood changes. Patients should seek immediate medical attention if any of these occur.

Levetiracetam is contraindicated in individuals with known hypersensitivity to the drug or any of its excipients. Caution is also advised for patients with severe renal impairment, as dose adjustments are required, and for those with a history of psychiatric disorders.